A Ruthenium–BODIPY Photosensitizer for Light-Triggered Apoptosis in Triple-Negative Breast Cancer Cells
Inorganic Chemistry · 2026
DOI: 10.1021/acs.inorgchem.6c01479 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, 2026. Verfasst von Ting-Hsuan Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Science and Engineering, The Chinese University of Hong Kong, Shenzhen, Guangdong 518172, China. Hauptthemen laut MEDLINE: Apoptosis, Photosensitizing Agents, Triple Negative Breast Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese University of Hong Kong, Shenzhen, National Taiwan University, National Science and Technology Council.
Abstract (Originalsprache)
The selective activation of therapeutic agents within the tumor microenvironment remains a cornerstone in enhancing the efficacy and safety of cancer treatments. This study introduces RuB3, an agent for photodynamic therapy (PDT), and explores its potential to selectively induce apoptosis in MDA-MB-231 breast cancer cells through controlled light exposure. Employing advanced live cell imaging techniques, fluorescence microscopy, and flow cytometry, we demonstrated that RuB3 facilitates targeted ROS generation and consequent apoptotic pathways upon light activation. Notably, RuB3 exhibited a substantial increase in apoptotic effects in a light-dependent manner, confirming its functionality as a PDT agent. Given its potent efficacy and minimal off-target effects, RuB3 represents a promising advancement in PDT approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Science and Engineering, The Chinese University of Hong Kong, Shenzhen, Guangdong 518172, China.
- Department of Chemistry, National Taiwan University, No. 1, Sec. 4, Roosevelt Rd., Taipei 10617, Taiwan (R.O.C.).
- Immune Research Core, Department of Medical Research, National Taiwan University Hospital, No. 7, Chung Shan S. Rd., Zhongzheng Dist., Taipei City 100225, Taiwan (R.O.C.).
- Shiv Nadar Institute of Eminence, Delhi-NCR, Greater Noida, Uttar Pradesh 201314, India.
- Center For Emerging Material and Advanced Devices, National Taiwan University, Taipei 10617, Taiwan.
ORCID-Profile: Sangeeta, Rakesh Ganguly, Kien Voon Kong, Tiow-Gan Ong
Förderung
- Chinese University of Hong Kong, Shenzhen
- National Taiwan University
- National Science and Technology Council
- National Talent Project
Zitieren
APA
Wang, T. H., Lin, C. H., Sim, E. Z., Cai-Syaun Wu, M., Hau-Ting Wei, J., Huang, W. T., Yu-Syun Fan, R., Pan, S. C., Sangeeta, Ganguly, R., Kong, K. V., & Ong, T. G. (2026). A Ruthenium–BODIPY Photosensitizer for Light-Triggered Apoptosis in Triple-Negative Breast Cancer Cells. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.6c01479
Vancouver
Wang TH, Lin CH, Sim EZ, Cai-Syaun Wu M, Hau-Ting Wei J, Huang WT, et al. A Ruthenium–BODIPY Photosensitizer for Light-Triggered Apoptosis in Triple-Negative Breast Cancer Cells. Inorganic Chemistry. 2026. doi:10.1021/acs.inorgchem.6c01479
BibTeX
@article{Wang2026,
author = {Wang, Ting-Hsuan and Lin, Chia-Hsuan and Sim, Eng Zhi and Cai-Syaun Wu, Melody and Hau-Ting Wei, Jack and Huang, Wan Tien and Yu-Syun Fan, Ricky and Pan, Siao-Cian and Sangeeta and Ganguly, Rakesh and Kong, Kien Voon and Ong, Tiow-Gan},
title = {A Ruthenium–BODIPY Photosensitizer for Light-Triggered Apoptosis in Triple-Negative Breast Cancer Cells},
journal = {Inorganic Chemistry},
year = {2026},
doi = {10.1021/acs.inorgchem.6c01479}
}
EUVIMED